Shopping Cart
- Remove All
Your shopping cart is currently empty
Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines. Dovramilast is used in the study of Mycobacterium tuberculosis infections and lupus erythematosus.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $126 | In Stock | |
| 2 mg | $186 | In Stock | |
| 5 mg | $313 | In Stock | |
| 10 mg | $496 | In Stock | |
| 25 mg | $953 | In Stock | |
| 50 mg | $1,490 | In Stock |
| Description | Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines. Dovramilast is used in the study of Mycobacterium tuberculosis infections and lupus erythematosus. |
| In vivo | In B6D2F1 mice, Dovramilast (5, 25, or 50 mg/kg; oral, single dose) reduces PDE4 expression in the lungs of mice infected with Mycobacterium tuberculosis (mtb)[1]. |
| Synonyms | CC-11050 |
| Molecular Weight | 472.55 |
| Formula | C24H28N2O6S |
| Cas No. | 340019-69-4 |
| Smiles | CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1Cc2cccc(NC(=O)C3CC3)c2C1=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 15 mg/mL (31.74 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.